1. Home
  2. Vol 51, No 4 (2019)
  3. Yang

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis

Sim Chun Yang, Ruslinda Mustafar, Lydia Kamaruzaman, Kong Wei Yen, Rozita Mohd, Rizna Cader

Abstract


A 59-year-old lady with underlying hypothyroidism presented with acute contact dermatitis progressed to cellulitis with superimposed bacterial infection and acute kidney injury. She responded to initial management with antibiotics, but a week later, she had cutaneous and systemic vasculitis. Her skin biopsy consistent with immune-mediated leuko-cytoclastic vasculitis and her blood test was positive for cytoplasmic-anti-neutrophil cytoplasmic antibody (c-ANCA). A diagnosis of ANCA-associated vasculitis was made and she was treated with immunosuppressant with plasmapheresis and hemodialysis support for her kidney failure. Despite aggressive measures, the patient succumbed to her illness. This case report demonstrates that soft tissue infection could trigger the development of ANCA-associated vasculitis whilst a background of hypothyroidism serves as a predisposing factor as both condition were reported separately in a couple of case studies before.

Keywords


cellulitis; anti-neutrophil cytoplasmic antibody; vasculitis

References


Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603-6.

McKinney EF, Willcocks LC, Broecker V, Smith KG. The immunopathology of ANCA-associated vasculitis. Seminars Immunopathol. 2014;36(4):461-78.

Savige J, Gillis D, Benson E, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). American J Clin Pathol. 1999;111(4):507-13.

Schonermarck U, Lamprecht P, Csernok E, Gross WL. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatol. 2001;40(2):178-84.

El-Ters M, Muthyala U, Philipneri MD, Hussein FA, Lentine KL. Immune-complex deposits in “pauci-immune” glomerulonephritis: a case report and brief review of recent literature. Arch Med Sci. 2010;6(4):633-7.

Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65(6):2145-52.

Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13:252.

Ray GT, Suaya JA, Baxter R. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Diagnos Microbiol Infecti Dis. 2013;76(1):24-30.

Munoz-Grajales C, Pineda JC. Pathophysiological relationship between infections and systemic vasculitis. Autoimmune Dis. 2015;2015:286783.

Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Annals of Intern Med. 1994;120(1):12-7.

Pendergraft WF, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nature Med. 2004;10(1):72-9.

Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity. 1993;15(3):245-52.

Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005;38(3):247-55.

Lionaki S, Hogan SL, Falk RJ, et al. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol Dial Transplant. 2007;22(12):3508-15.

Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T. Concealed hypothyroidism in patients with myeloperoxidase antineutrophili cytoplasmic autoantibodies- (MPO-ANCA) positive renal disease. Clin Nephrol. 1999;52(2):91-5.

Lai Y, Nik Yahya NH, Ong SG. ANCA-associated vasculitis - revisited, and its association with autoimmune thyroid disease. Med J Malaysia. 2014;69(2):98-100.

Vanderpump MP. The epidemiology of thyroid disease. British Med Bulletin. 2011;99:39-51.

Belaconi IN, Toma CL, Bogdan MA. [Uptodate in the management and treatment of ANCA-associated vasculitis]. Pneumologia. 2014;63(2):78-80, 3-6.

Hamour S, Salama AD, Pusey CD. Management of ANCA-associated vasculitis: Current trends and future prospects. Ther Clin Risk Manag. 2010;6:253-64.

Walters G. Role of therapeutic plasmapheresis in ANCA-associated vasculitis. Pediatric Nephrol. 2016;31(2):217-25.

Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA. Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies. Annals Rheumatic Dis. 2017;76(9):1566-74.

Weiner M, Goh SM, Mohammad AJ, et al. Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clin J Am Soc Nephrol: CJASN. 2015;10(7):1128-35.


Full Text: PDF

Refbacks

  • There are currently no refbacks.